-+ 0.00%
-+ 0.00%
-+ 0.00%

Tempest Therapeutics appoints Nancy Freda-Smith to board, names her audit committee chair

PUBT·09/23/2026 12:04:05
Listen to the news
Tempest Therapeutics appoints Nancy Freda-Smith to board, names her audit committee chair
  • Tempest Therapeutics appointed Nancy Freda-Smith to its board of directors.
  • Freda-Smith will serve as chair of the board’s audit committee.
  • She most recently served as chief audit and risk officer at Ralph Lauren.
  • Earlier roles include managing director at Deloitte & Touche, advising Fortune 500 clients on SEC reporting, capital markets deals, U.S. GAAP, IFRS.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Tempest Therapeutics Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202609230800PRIMZONEFULLFEED9832050) on September 23, 2026, and is solely responsible for the information contained therein.